Fiduciary Alliance’s Gilead Sciences GILD Stock Holding History

Fiduciary Alliance’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$304K	Sell	2,409 -344	-12%	-$45.3K	0.02%	439
2026 Q1	$385K	Sell	2,753 -19	-0.7%	-$2.66K	0.02%	404
2025 Q4	$340K	Buy	2,772 +50	+2%	+$6.08K	0.02%	403
2025 Q3	$302K	Buy	2,722 +162	+6%	+$18.4K	0.02%	414
2025 Q2	$284K	Buy	+2,560	New	+$272K	0.02%	400
2023 Q3	–	Sell	-75	Closed	-$5.78K	–	476
2023 Q2	$5.78K	Buy	+75	New	+$5.98K	﹤0.01%	671
2023 Q1	–	Sell	-75	Closed	-$6.44K	–	420
2022 Q4	$6.44K	Buy	+75	New	+$5.94K	﹤0.01%	481

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fiduciary Alliance's GILD Position: Q2 2026 in Review

Fiduciary Alliance reduced its Gilead Sciences (GILD) stake by 12% in Q2 2026, selling an estimated $45.3K and leaving 2,409 shares worth $304K. The position accounts for 0.02% of the portfolio, ranked #439.

Fiduciary Alliance first reported a position in GILD in Q4 2022 and has held it in 7 quarters since. The position peaked at $385K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Fiduciary Alliance held 2,409 shares of Gilead Sciences worth $304K as of Q2 2026.
Fiduciary Alliance sold 344 Gilead Sciences shares in Q2 2026, an estimated $45.3K.
Gilead Sciences made up 0.02% of Fiduciary Alliance's portfolio in Q2 2026, its #439 holding.
Fiduciary Alliance first reported a position in Gilead Sciences in Q4 2022 and has held it in 7 quarters since.
Fiduciary Alliance's Gilead Sciences position peaked at $385K in Q1 2026.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fiduciary Alliance's 13F filing for Q2 2026, filed 20 Jul 2026.